RT @JNeurooncol: #OnlineFirst: Ciesielski and colleagues show the small molecule dual Src/tubulin inhibitor KX2-361 can be effective in the…
RT @JNeurooncol: #OnlineFirst: Ciesielski and colleagues show the small molecule dual Src/tubulin inhibitor KX2-361 can be effective in the…
RT @JNeurooncol: #OnlineFirst: Ciesielski and colleagues show the small molecule dual Src/tubulin inhibitor KX2-361 can be effective in the…
RT @JNeurooncol: #OnlineFirst: Ciesielski and colleagues show the small molecule dual Src/tubulin inhibitor KX2-361 can be effective in the…
RT @JNeurooncol: #OnlineFirst: Ciesielski and colleagues show the small molecule dual Src/tubulin inhibitor KX2-361 can be effective in the…
RT @JNeurooncol: #OnlineFirst: Ciesielski and colleagues show the small molecule dual Src/tubulin inhibitor KX2-361 can be effective in the…
#OnlineFirst: Ciesielski and colleagues show the small molecule dual Src/tubulin inhibitor KX2-361 can be effective in the GL261 murine model of glioblastoma. https://t.co/1hOCbnySJQ https://t.co/hL93RJatR4
KX2-361: a novel orally bioavailable small molecule dual Src/tubulin inhibitor that provides long term survival in a murine model of glioblastoma. https://t.co/H8JpBAeGj5
KX2-361: a novel orally bioavailable small molecule dual Src/tubulin inhibitor that provides long term survival in a murine model of glioblastoma. https://t.co/cjR0I2Tmca
#newupdatesneuroonc #braintumours #neuroonc KX2-361: a novel orally bioavailable small molecule dual Src/tubulin inhibitor that provides long term survival in a murine model of glioblastoma - https://t.co/qhMC0UmfvT